Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07297953 · ClinicalTrials.gov registry record · NA
Access Sheath and Stent Trial
A NA study of Kidney Stone and Ureteral Stone, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 184
- Enrollment target
- 1
- Study location
NCT07297953: Recruiting NA study of Kidney Stone and Ureteral Stone, sponsored by University of Michigan.
NCT07297953 is a NA study of Kidney Stone and Ureteral Stone that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 184 participants, roughly in line with the 186-participant average among 28 other Kidney Stone trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07297953, a NA study of Kidney Stone and Ureteral Stone, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is being completed to compare patient reported outcomes for stent omission vs. placement after using a ureteral access sheath for uncomplicated ureteroscopy. Participants that consent for the study will complete baseline PRO questionnaires. A UAS will be used during surgery, and the size left to the discretion of the surgeon. At the end of the procedure, the urologist will evaluate the ureter for iatrogenic injury, and the ureter will be graded using the Post Ureteroscopic Lesion Scale (PULS). Patients assessed with PULS 0 and PULS 1 will meet 2nd stage eligibility and will be randomized 1:1 to either stent omission or stent placement. When a stent is placed, the stent type and decision to leave a string (tether) will be at the operating urologist's discretion. Hypothesis: \- stent omission arm will be non-inferior to stent placement in Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference and Pain Intensity, and have lower 30-day healthcare utilization.
Primary Outcome
This is a 6-item survey which participants select a response for each item from 1=not at all to 5=very much for how much pain interfered with their life. The scores range from 6-30 with a higher score indicating greater interference.
Conditions Studied
Interventions
- OTHER Surveys
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2025-09-24 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT07297953 shows while recruiting
NCT07297953 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 186-participant average among 28 other Kidney Stone trials with a reported enrollment target.
The record links to 2 conditions, with Kidney Stone appearing as the primary indexed condition, and to 1 intervention - of which Surveys is the first listed.
NCT07297953 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07297953 about?
NCT07297953 is a clinical study titled "Access Sheath and Stent Trial". The study is being completed to compare patient reported outcomes for stent omission vs. placement after using a ureteral access sheath for uncomplicated ureteroscopy. Participants that consent for the study will complete baseline PRO questionnaires. A UAS will be used during surgery, and the size ...
What is the current status of trial NCT07297953?
This trial is currently recruiting. It is a NA study. The enrollment target is 184 participants. The study started on 2025-09-24. Estimated completion is 2026-10.
What conditions does trial NCT07297953 study?
This clinical trial studies the following conditions: Kidney Stone, Ureteral Stone.
What interventions are being tested in trial NCT07297953?
The interventions under investigation include: Surveys (OTHER).
Who is sponsoring clinical trial NCT07297953?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07297953 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Stone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07297953's enrollment target sits among peer trials
184 3rd of 28 higher than 26 of 28 other Kidney Stone trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Stone trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy
RECRUITING · NA
-
GI Oxalate Absorption
RECRUITING · NA
-
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
RECRUITING · NA
-
O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI